For example, CDK10 mRNA and/or protein levels were found downregulated in biliary tract carcinomas [22], hepatocellular carcinomas [58], low-grade and, to a lesser extent, high-grade glial tumors [59] and breast cancer tissues compared to adjacent noncancerous tissues [64]. This evidence concerns the gene CDK10 and hepatocellular carcinoma.